G&E Herbal Biotechnology Co., Ltd. (TPEX: 4911)

G&E Herbal Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,156	3,440	2,972	1,558	1,940	2,004
Market Cap Growth	-23.42%	15.73%	90.71%	-19.66%	-3.19%	1.55%
Enterprise Value	2,835	3,226	2,849	1,446	1,819	1,874
Last Close Price	53.50	57.72	49.87	26.15	32.55	33.62
PE Ratio	37.66	47.06	406.77	-77.59	-134.26	-84.90
PS Ratio	14.95	18.96	46.00	63.43	68.71	114.15
PB Ratio	4.07	4.51	4.30	2.28	2.76	2.79
P/FCF Ratio	24.41	31.86	30.64	-142.17	-458.68	-77.63
P/OCF Ratio	24.75	30.31	29.73	-169.57	2515.89	-103.26
EV/Sales Ratio	13.42	17.78	44.10	58.83	64.44	106.75
EV/EBITDA Ratio	27.45	35.83	191.43	-141.35	-290.45	-96.31
EV/EBIT Ratio	30.36	39.98	519.39	-73.90	-117.56	-65.35
EV/FCF Ratio	21.92	29.88	29.37	-131.87	-430.15	-72.60
Debt / Equity Ratio	0.00	0.00	-	-	-	-
Debt / EBITDA Ratio	0.02	0.02	-	-	-	-
Debt / FCF Ratio	0.02	0.02	-	-	-	-
Asset Turnover	0.26	0.22	0.09	0.04	0.04	0.02
Inventory Turnover	1.80	1.55	1.14	0.81	1.07	1.38
Quick Ratio	3.39	2.77	2.25	13.14	15.04	10.63
Current Ratio	3.61	2.97	2.54	15.66	17.42	12.77
Return on Equity (ROE)	11.20%	9.96%	1.07%	-2.87%	-2.01%	-3.20%
Return on Assets (ROA)	7.09%	6.05%	0.46%	-1.74%	-1.34%	-2.41%
Return on Capital (ROIC)	7.78%	6.93%	0.50%	-1.76%	-1.36%	-2.46%
Earnings Yield	2.66%	2.10%	0.25%	-1.28%	-0.74%	-1.17%
FCF Yield	4.10%	3.14%	3.26%	-0.70%	-0.22%	-1.29%
Dividend Yield	1.00%	0.93%	-	-	-	-
Buyback Yield / Dilution	-0.10%	-0.08%	-	-	-	-
Total Shareholder Return	0.90%	0.85%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.